IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 7,080.00
+600.00 (9.26%)
Apr 1, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 99.25 billion as of April 1, 2026. Its market cap has decreased by -34.51% in one year.
Market Cap
99.25B
Enterprise Value
79.01B
Revenue
5.33B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,080.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 99.25B, a decrease of -80.30%. That is a compound annual growth rate of -55.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 90.84B | -34.48% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 226.94B |
| MedPacto | 195.37B |
| Vaxcell-Bio Therapeutics | 181.64B |
| Macrogen | 180.40B |
| ENCell | 173.35B |
| Amicogen | 128.86B |
| iNtRON Biotechnology | 127.22B |
| CG Invites | 125.88B |